首页> 外文期刊>Science >Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer
【24h】

Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer

机译:泛素体组分析确定SPOP突变型前列腺癌中效应底物的失调

获取原文
获取原文并翻译 | 示例
       

摘要

Cancer genome characterization has revealed driver mutations in genes that govern ubiquitylation; however, the mechanisms by which these alterations promote tumorigenesis remain incompletely characterized. Here, we analyzed changes in the ubiquitin landscape induced by prostate cancer-associated mutations of SPOP, an E3 ubiquitin ligase substrate-binding protein. SPOP mutants impaired ubiquitylation of a subset of proteins in a dominant-negative fashion. Of these, DEK and TRIM24 emerged as effector substrates consistently up-regulated by SPOP mutants. We highlight DEK as a SPOP substrate that exhibited decreases in ubiquitylation and proteasomal degradation resulting from heteromeric complexes of wild-type and mutant SPOP protein. DEK stabilization promoted prostate epithelial cell invasion, which implicated DEK as an oncogenic effector. More generally, these results provide a framework to decipher tumorigenic mechanisms linked to dysregulated ubiquitylation.
机译:癌症基因组表征已经揭示了控制泛素化的基因中的驱动程序突变。然而,这些改变促进肿瘤发生的机制仍未完全表征。在这里,我们分析了由前列腺癌相关的SPOP(E3泛素连接酶底物结合蛋白)突变引起的泛素景观变化。 SPOP突变体以显性负性方式破坏了一部分蛋白质的泛素化。其中,DEK和TRIM24作为效应底物出现,并持续受SPOP突变体上调。我们强调DEK作为SPOP底物,由于野生型和突变SPOP蛋白质的异聚复合物而导致泛素化和蛋白酶体降解降低。 DEK稳定促进前列腺上皮细胞的侵袭,这暗示DEK是致癌效应物。更普遍地,这些结果提供了一个框架,以破译与泛素化失调有关的致瘤机制。

著录项

  • 来源
    《Science》 |2014年第6205期|85-89|共5页
  • 作者单位

    Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.;

    Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.;

    Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada.;

    Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.;

    Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.;

    Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.;

    Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland.;

    Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA.;

    Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.;

    Weill Cornell & New York Presbyterian Hosp, Inst Precis Med, New York, NY 10065 USA.;

    Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland.;

    Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada.;

    Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.;

    Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA.;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:52:30

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号